XML 49 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Marketable Securities
12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

3. Marketable Securities

 

A summary of the Company’s cash equivalents and marketable securities as of December 31, 2021 and 2020, which are recorded at fair value (and excludes $405.6 million and $395.1 million of cash at December 31, 2021 and 2020, respectively) is shown below (in thousands):

 

December 31, 2021

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

507,386

 

 

$

 

 

$

 

 

$

507,386

 

Corporate debt securities

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

9,997

 

 

 

 

 

 

(1

)

 

 

9,996

 

Total cash equivalents

 

 

517,383

 

 

 

 

 

 

(1

)

 

 

517,382

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

16,238

 

 

 

6

 

 

 

(52

)

 

 

16,192

 

Corporate debt securities

 

 

1,173,659

 

 

 

10

 

 

 

(4,903

)

 

 

1,168,766

 

Certificates of deposit

 

 

45,164

 

 

 

 

 

 

 

 

 

45,164

 

Government-sponsored enterprise securities

 

 

13,334

 

 

 

 

 

 

(77

)

 

 

13,257

 

Commercial paper

 

 

212,805

 

 

 

 

 

 

(86

)

 

 

212,719

 

Total marketable securities

 

 

1,461,200

 

 

 

16

 

 

 

(5,118

)

 

 

1,456,098

 

Total cash equivalents and marketable securities

 

$

1,978,583

 

 

$

16

 

 

$

(5,119

)

 

$

1,973,480

 

 

December 31, 2020

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

742,958

 

 

$

 

 

$

 

 

$

742,958

 

Corporate debt securities

 

 

2,526

 

 

 

1

 

 

 

(24

)

 

 

2,503

 

Certificates of deposit

 

 

12,527

 

 

 

 

 

 

 

 

 

12,527

 

Commercial paper

 

 

15,549

 

 

 

 

 

 

 

 

 

15,549

 

Total cash equivalents

 

 

773,560

 

 

 

1

 

 

 

(24

)

 

 

773,537

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

47,976

 

 

 

3

 

 

 

 

 

 

47,979

 

Corporate debt securities

 

 

324,569

 

 

 

43

 

 

 

(156

)

 

 

324,456

 

Certificates of deposit

 

 

25,162

 

 

 

 

 

 

 

 

 

25,162

 

Government-sponsored enterprise securities

 

 

33,738

 

 

 

5

 

 

 

(2

)

 

 

33,741

 

Commercial paper

 

 

90,375

 

 

 

 

 

 

 

 

 

90,375

 

Total marketable securities

 

 

521,820

 

 

 

51

 

 

 

(158

)

 

 

521,713

 

Total cash equivalents and marketable securities

 

$

1,295,380

 

 

$

52

 

 

$

(182

)

 

$

1,295,250

 

 

As of December 31, 2021 and 2020, the aggregate fair value of marketable securities that were in an unrealized loss position for less than twelve months was $1,311.6 million and $280.3 million, respectively. As of December 31, 2021, the aggregate fair value of marketable securities that were in an unrealized loss position for more than twelve months was $4.6 million. As of December 31,

2020, no marketable securities were in an unrealized loss position for more than twelve months. The Company has recorded a net unrealized loss of $5.0 million and $0.1 million, respectively, during the years ended December 31, 2021 and 2020 related to its marketable securities, which is included in comprehensive income (loss) on the consolidated statements of operations and comprehensive income (loss). No net unrealized loss was recorded related to its marketable securities for the year ended December 31, 2019.

 

The Company determined that there was no material credit risk of the above investments as of December 31, 2021. The Company has the intent and ability to hold such securities until recovery. As a result, the Company did not record any charges for credit-related impairments for its marketable securities for the years ended December 31, 2021 and 2020.